OPNT - オピアント・ファ―マシュ―ティカルズ (Opiant Pharmaceuticals Inc.) オピアント・ファ―マシュ―ティカルズ

 OPNTのチャート


 OPNTの企業情報

symbol OPNT
会社名 Opiant Pharmaceuticals Inc (オピアント・ファ―マシュ―ティカルズ)
分野(sector) Basic Industries   素材
産業(industry) Precious Metals  
業種 医薬品   医療関連(Health Care)
概要 事業概要 Opiant Pharmaceuticals Inc. formerly Lightlake Therapeutics Inc. is a specialty pharmaceutical company. The Company develops pharmacological treatments for substance use addictive and eating disorders. The Company has developed NARCAN (naloxone hydrochloride) Nasal Spray a treatment to reverse opioid overdoses which was conceived licensed developed and approved by the United States Food and Drug Administration (FDA). The Company's pipeline of product candidates includes a treatment for Binge Eating Disorder (BED) a treatment for Bulimia Nervosa (BN) a treatment for Cocaine Use Disorder (CocUD) and a heroin vaccine. The Company also is focused on other treatment opportunities.   オピアント・ファ―マシュ―ティカルズは米国の専門製薬会社。主に薬物使用、中毒、摂食障害に対する治療法の開発に従事する。オピオイド系鎮痛剤の過剰摂取をリバ―スさせるナロキソン塩酸塩「NARCAN」鼻腔用スプレ―を開発。同社製品候補には過食症治療薬、コカイン使用障害治療薬、ヘロインワクチンが含まれる。本社所在地はカリフォルニア州サンタ・モニカ。   Opiant Pharmaceuticals, Inc. engages in the development of pharmaceutical solutions for common addictions and related disorders. It focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. Opiant Pharmaceuticals was founded on June 21, 2005 and is headquartered in Santa Monica, CA.
本社所在地 201 Santa Monica Boulevard Suite 500 Santa Monica CA 90401 USA
代表者氏名 Michael J. Sinclair マイケル・シンクレア
代表者役職名 Executive Chairman of the Board 取締役会長
電話番号 +1 310-598-5410
設立年月日 38504
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 14人
url www.lightlaketherapeutics.com
nasdaq_url https://www.nasdaq.com/symbol/opnt
adr_tso
EBITDA EBITDA(百万ドル) -9.08382
終値(lastsale) 17.27
時価総額(marketcap) 63701206.69
時価総額 時価総額(百万ドル) 58.81564
売上高 売上高(百万ドル) 16.61532
企業価値(EV) 企業価値(EV)(百万ドル) 47.57064
当期純利益 当期純利益(百万ドル) -9.36162
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Opiant Pharmaceuticals Inc revenues totaled $4.9M. Net loss totaled to $10.7M. Results are not comparable due to year end change.

 OPNTのテクニカル分析


 OPNTのニュース

   Opiant Pharmaceuticals, Inc. (OPNT): Hedge Funds Watching From Afar  2019/11/24 21:25:35 Yahoo Finance
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors' consensus returns have been exceptional
   Opiant Pharmaceuticals, Inc. (OPNT) CEO Roger Crystal on Q1 2019 Results - Earnings Call Transcript  2019/05/13 03:01:35 Seeking Alpha
   Opiant Pharmaceuticals beats by $0.35, beats on revenue  2019/05/09 20:39:51 Seeking Alpha
   The Daily Biotech Pulse: FDA Nod For Sanofi's Dengue Vaccine, Veracyte Offering, Biogen Reports Positive Data  2019/05/02 12:16:16 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 1) Alcon AG (NYSE: ALC ) (announced presentation of new clinical data and innovative technology at the Cataract Refractive Suite during the American Society of Cataract and Refractive Surgery) Down In The Dumps (Biotech stocks hitting 52-week lows on May 2) Acorda Therapeutics Inc (NASDAQ: ACOR ) Aptevo Therapeutics Inc (NASDAQ: APVO ) Athenex Inc (NASDAQ: ATNX ) Auris Medical Holding Ltd (NASDAQ: EARS )(began to trade on a reverse stock-split adjusted basis) Caladrius Biosciences Inc (NASDAQ: CLBS ) Eyegate Pharmaceuticals Inc (NASDAQ: EYEG ) Heron Therapeutics Inc (NASDAQ: HRTX )(stymied by a CRL issued for its post-operative pain medication) KemPharm Inc (NASDAQ: KMPH ) Opiant Pharmaceuticals Inc (NASDAQ: OPNT ) Psychemedics Corp. (NASDAQ: PMD ) Strongbridge Biopharma plc (NASDAQ: SBBP ) (reacted to its first quarter results) Related Link: Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates Stock In Focus FDA Okays Sanofi's Dengue Vaccine With Restrictions Sanofi SA (NASDAQ: SNY ) said the FDA approved its Dengvaxia for the prevention of dengue disease caused by serotypes 1-4 of the virus in individuals 9 through 16 years of age living in endemic areas of the U.S. with a lab-documented prior infection.
   First exec indicted over role in opioid crisis  2019/04/23 16:26:30 Seeking Alpha
   Opiant Pharmaceuticals, Inc. (OPNT): Hedge Funds Watching From Afar  2019/11/24 21:25:35 Yahoo Finance
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors' consensus returns have been exceptional
   Opiant Pharmaceuticals, Inc. (OPNT) CEO Roger Crystal on Q1 2019 Results - Earnings Call Transcript  2019/05/13 03:01:35 Seeking Alpha
   Opiant Pharmaceuticals beats by $0.35, beats on revenue  2019/05/09 20:39:51 Seeking Alpha
   The Daily Biotech Pulse: FDA Nod For Sanofi's Dengue Vaccine, Veracyte Offering, Biogen Reports Positive Data  2019/05/02 12:16:16 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 1) Alcon AG (NYSE: ALC ) (announced presentation of new clinical data and innovative technology at the Cataract Refractive Suite during the American Society of Cataract and Refractive Surgery) Down In The Dumps (Biotech stocks hitting 52-week lows on May 2) Acorda Therapeutics Inc (NASDAQ: ACOR ) Aptevo Therapeutics Inc (NASDAQ: APVO ) Athenex Inc (NASDAQ: ATNX ) Auris Medical Holding Ltd (NASDAQ: EARS )(began to trade on a reverse stock-split adjusted basis) Caladrius Biosciences Inc (NASDAQ: CLBS ) Eyegate Pharmaceuticals Inc (NASDAQ: EYEG ) Heron Therapeutics Inc (NASDAQ: HRTX )(stymied by a CRL issued for its post-operative pain medication) KemPharm Inc (NASDAQ: KMPH ) Opiant Pharmaceuticals Inc (NASDAQ: OPNT ) Psychemedics Corp. (NASDAQ: PMD ) Strongbridge Biopharma plc (NASDAQ: SBBP ) (reacted to its first quarter results) Related Link: Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates Stock In Focus FDA Okays Sanofi's Dengue Vaccine With Restrictions Sanofi SA (NASDAQ: SNY ) said the FDA approved its Dengvaxia for the prevention of dengue disease caused by serotypes 1-4 of the virus in individuals 9 through 16 years of age living in endemic areas of the U.S. with a lab-documented prior infection.
   First exec indicted over role in opioid crisis  2019/04/23 16:26:30 Seeking Alpha
   Opiant Pharmaceuticals, Inc. (OPNT): Hedge Funds Watching From Afar  2019/11/24 21:25:35 Yahoo Finance
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors' consensus returns have been exceptional
   Opiant Pharmaceuticals, Inc. (OPNT) CEO Roger Crystal on Q1 2019 Results - Earnings Call Transcript  2019/05/13 03:01:35 Seeking Alpha
   Opiant Pharmaceuticals beats by $0.35, beats on revenue  2019/05/09 20:39:51 Seeking Alpha
   The Daily Biotech Pulse: FDA Nod For Sanofi's Dengue Vaccine, Veracyte Offering, Biogen Reports Positive Data  2019/05/02 12:16:16 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 1) Alcon AG (NYSE: ALC ) (announced presentation of new clinical data and innovative technology at the Cataract Refractive Suite during the American Society of Cataract and Refractive Surgery) Down In The Dumps (Biotech stocks hitting 52-week lows on May 2) Acorda Therapeutics Inc (NASDAQ: ACOR ) Aptevo Therapeutics Inc (NASDAQ: APVO ) Athenex Inc (NASDAQ: ATNX ) Auris Medical Holding Ltd (NASDAQ: EARS )(began to trade on a reverse stock-split adjusted basis) Caladrius Biosciences Inc (NASDAQ: CLBS ) Eyegate Pharmaceuticals Inc (NASDAQ: EYEG ) Heron Therapeutics Inc (NASDAQ: HRTX )(stymied by a CRL issued for its post-operative pain medication) KemPharm Inc (NASDAQ: KMPH ) Opiant Pharmaceuticals Inc (NASDAQ: OPNT ) Psychemedics Corp. (NASDAQ: PMD ) Strongbridge Biopharma plc (NASDAQ: SBBP ) (reacted to its first quarter results) Related Link: Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates Stock In Focus FDA Okays Sanofi's Dengue Vaccine With Restrictions Sanofi SA (NASDAQ: SNY ) said the FDA approved its Dengvaxia for the prevention of dengue disease caused by serotypes 1-4 of the virus in individuals 9 through 16 years of age living in endemic areas of the U.S. with a lab-documented prior infection.
   First exec indicted over role in opioid crisis  2019/04/23 16:26:30 Seeking Alpha

 関連キーワード  (医薬品 米国株 オピアント・ファ―マシュ―ティカルズ OPNT Opiant Pharmaceuticals Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)